Rare diseases
Investigational molecules
Locations
213 conditions with trials, the busiest first
504 trials across Europe, recruiting first
Efficacy and safety of osilodrostat with drug combination in patients with hypertension caused by Cushing's syndrome
BulgariaEfficacy, safety and dose‑response of once‑weekly subcutaneous UBT251 compared with semaglutide in adults with type 2 diabetes
GermanyPhase 3 Randomized Placebo‑Controlled Study of Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs
BelgiumRandomized trial of elecoglipron with dapagliflozin versus placebo in adults with type 2 diabetes mellitus and impaired renal function
BulgariaPhase II study of intratumoral getacatetide in patients with locally advanced or metastatic adrenocortical carcinoma
FranceSafety and Pharmacokinetic Dose-Escalation Study of IMC-S118AI and Sodium Chloride in HLA‑A*02:01‑Positive Participants with Type 1 Diabetes
AustriaStudy of Follitropin Delta, Triptorelin and Choriogonadotropin Alfa for Ovulation Trigger in IVF with Fresh Transfer in Women with Low Ovarian Reserve
SpainFluoroethyltyrosine F-18 PET Scan for Adults with Suspected Functional Pituitary Adenoma and Unclear MRI Results
FranceStudy of hu14.18K322A with temozolomide and irinotecan in children and adolescents with high‑risk neuroblastoma
DenmarkEffect of dapagliflozin and semaglutide on heart insulin resistance in type 2 diabetes patients
SpainAMG 732 in Patients With Thyroid Eye Disease Who Did Not Respond or Relapsed After Previous Treatment
FranceNaxitamab Added to Standard Induction Therapy for Children and Teenagers with Newly Diagnosed High-Risk Neuroblastoma
SpainThe therapies tested most often in Endocrine disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
